Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0001510281 XXXXXXXX LIVE 5 Common Shares, $0.001 par value 12/17/2025 false 0000855887 09662E109 BNY Mellon Strategic Municipal Bond Fund, Inc. 240 Greenwich Street New York NY 10286 Saba Capital Management, L.P. (212) 542-4635 405 Lexington Avenue, 58th Floor Attention: Michael D'Angelo New York NY 10174 0001510281 N Saba Capital Management, L.P. OO N DE 0 5179441 0 5179441 5179441 N 10.31 PN IA The percentages used herein are calculated based upon 50,247,708 shares of common stock outstanding as of 8/22/25, as disclosed in the company's DEF 14A filed 9/26/25. 0001608233 N Boaz R. Weinstein OO N NY 0 5179441 0 5179441 5179441 N 10.31 OO The percentages used herein are calculated based upon 50,247,708 shares of common stock outstanding as of 8/22/25, as disclosed in the company's DEF 14A filed 9/26/25. Y Saba Capital Management GP, LLC OO N DE 0 5179441 0 5179441 5179441 N 10.31 OO The percentages used herein are calculated based upon 50,247,708 shares of common stock outstanding as of 8/22/25, as disclosed in the company's DEF 14A filed 9/26/25. Common Shares, $0.001 par value BNY Mellon Strategic Municipal Bond Fund, Inc. 240 Greenwich Street New York NY 10286 This Amendment No. 5 amends Items 3, 4, 5, and 7. This Schedule 13D/A is being jointly filed by: (i) Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"); (ii) Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"); and (iii) Mr. Boaz R. Weinstein ("Mr. Weinstein"), (together, the "Reporting Persons"). Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Sections 13 of the Securities Exchange Act of 1934, the beneficial owner of the Common Shares reported herein. The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174. The principal business of: (i) Saba Capital is to serve as investment manager to private and public investment funds and/or accounts, (ii) Saba GP is to serve as general partner of the Saba Capital and other affiliated entities, and (iii) Mr. Weinstein, an individual, is managing member of the general partner of Saba Capital and other affiliated entities. The Reporting Persons have not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). The Reporting Persons have not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws. Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States. Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $28,937,208 was paid to acquire the Common Shares reported herein. On December 17, 2025, Saba Capital sent a letter (the "Letter") to the Issuer's Chairman of the Board of Trustees (i) expressing concerns with the long-term viability of the Issuer, (ii) disclosing Saba Capital's intent to nominate trustee candidates at the Issuer's 2026 annual meeting of shareholders, and (iii) encouraging the Issuer's board of trustees to proactively consider a value-enhancing merger. The foregoing summary of the Letter does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter, a copy of which is attached as Exhibit 3 and incorporated by reference herein. See the Reporting Persons section of this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 50,247,708 shares of common stock outstanding as of 8/22/25, as disclosed in the company's DEF 14A filed 9/26/25. See the Reporting Persons section of this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. The transactions in the Common Shares effected by the Reporting Persons within the past sixty days are set forth in Schedule A and are incorporated herein by reference. Unless otherwise indicated, all trades were effected in the open market. The funds and accounts advised by Saba Capital have the right to receive the dividends and proceeds of sales from the Common Shares. Not Applicable. Exhibit 3 - The Letter Exhibit 4 - Schedule A Saba Capital Management, L.P. /s/ Michael D'Angelo General Counsel 12/17/2025 Boaz R. Weinstein /s/ Michael D'Angelo Authorized Signatory 12/17/2025 Saba Capital Management GP, LLC /s/ Michael D'Angelo Attorney-in-fact* 12/17/2025 Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823